Burford Capital (NYSE:BUR) Stock

Burford Capital

Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.

Burford Capital Ltd

BURBERRY GROUP PLC S/ADR by Burberry Group Plc

Burberry Group PLC

BURNHAM HLDGS INC A by Burnham Holdings, Inc.

Burnham Holdings Inc

BURNHAM HLDGS INC B by Burnham Holdings, Inc.

Basin Uranium Corp

BURNHAM HLDGS INC 6 PFD by Burnham Holdings, Inc.

Burger Swap

Burlington Stores Inc

Nuburu Inc

Nuburu Inc Class A

Burford Capital Limited ("Burford"), the leading global finance and asset management firm focused on law, today issues the following update to its June 17, June 30, and July 1, 2025 statements in connection with proposed tax provisions relating to litigation finance included within the US Senate's draft of the budget reconciliation bill.
Based on the Senate Parliamentarian's ruling that those provisions were not eligible for inclusion in the bill, they were removed. The bill has now been adopted by the Senate without containing those provisions.

News

Burford Capital Issues Update As U.S. Senate Excludes Litigation Finance Tax Proposal

Burford Capital Reports Key Court Order In Argentina Enforcement; YPF Shares To Be Transferred Via BNY Mellon

Burford Capital Limited ("Burford"), the leading global finance and asset management firm focused on law, today issues the following update to its June 17, 2025 statement in connection with proposed tax provisions relating to litigation finance included within the US Senate's draft of the budget reconciliation bill.
In revisions to the bill over the weekend, the proposed tax rate has been reduced to 31.8% (instead of 40.8%) and the withholding tax rate has been reduced to 15.9% of gains (instead of 50% of the tax rate applied to gross proceeds).
In response to those changes, the nonpartisan Joint Committee on Taxation reduced its estimates of the expected tax revenue the provisions could generate over the next decade to $1.4 billion; prior estimates were as high as $3.5 billion.
The Senate continues to debate the legislation, and there remain a number of uncertain procedural and political steps both for the litigation finance provisions and the bill itself before enactment could occur.&nbsp; The outcome of those steps, including the failure to enact the provisions at all, remains unpredictable.&nbsp; Moreover, as discussed in the prior statement, Burford is not yet able to assess the impact of those provisions, if enacted in their current form, on its future tax position.

Burford Capital Issues Update On U.S. Tax Proposal As Litigation Finance Rate Cut To 31.8%

Wedbush analyst Jay McCanless assumes Burford Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>) with a Outperform rating and announces Price Target of $18.

Price Target

Initiation

Analyst Ratings

Wedbush Assumes Burford Capital at Outperform, Announces Price Target of $18

Burford Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.18 by 22.22 percent. This is a 200 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $118.86 million which beat the analyst consensus estimate of $107.49 million by 10.58 percent. This is a 168.34 percent increase over sales of $44.30 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Burford Capital Q1 EPS $0.14 Misses $0.18 Estimate, Sales $118.86M Beat $107.49M Estimate

ACAD

ACDC

ACRE

ACVA

ADMA

ADNT

ADTN

AIRG

ALNT

ALTG

ALTO

ALVO

AMPH

AMPL

AMRK

AMRN

AOSL

APLS

ARIS

ARMN

ASLE

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AVDX

AXON

AXTA

AZTA

BAND

BBDO

BBGI

BBSI

BGSF

Brighthouse Financial, Inc. - Common Stock

BLBD

BLMN

BLZE

BMBL

BRKR

BROS

BTMD

BXSL

BYND

CAPL

CCSI

CDLX

CENT

CENTA

CENX

CEVA

CIVI

CMTG

CNDT

COHR

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRNC

CRNT

CSGS

CSTE

CTVA

CVNA

CYRX

Earnings Scheduled For May 7, 2025

Burford Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-05-07. Here's what investors need to know before the announcement.
Analysts estimate that Burford Capital will report an earnings per share (EPS) of $0.25. 
Investors in Burford Capital are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Past Earnings Performance</h3>
The company's EPS missed by $0.62 in the last quarter, leading to a 5.04% drop in the share price on the following day.
Here's a look at Burford Capital's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.56</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.06</td>
<td>0.61</td>
<td>0.24</td>
<td>-0.14</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-5.0%</td>
<td>-3.0%</td>
<td>3.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<h3>Burford Capital Share Price Analysis</h3>
Shares of Burford Capital were trading at $13.95 as of May 05. Over the last 52-week period, shares are down 14.11%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/BUR/earnings">To track all earnings releases for Burford Capital visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Uncovering Potential: Burford Capital's Earnings Preview

WIIM

AGNC

BANC

BXMT

COIN

COLB

CRBG

DBRG

FULT

FUTU

GGAL

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HOOD

INTR

ITUB

Janus Henderson Group plc Ordinary Shares

MUFG

SMFG

STWD

UPST

Shares of companies in the broader financial services sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

ACGL

ALLY

ARCC

ARES

CADE

EWBC

FITB

HBAN

HOMB

HSBC

IBKR

NDAQ

OBDC

SOFI

TROW

VOYA

Shares of banks and financial services companies are trading higher amid an overall market surge following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

AGMH

BENF

CNCK

EMCG

FRHC

LGHL

MSCI

NTRS

PIPR

PMAX

VCTR

Shares of companies within the broader financial sector are trading lower amid President Trump's decision to implement tariffs.

Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digested a decline in February's ISM Manufacturing PMI data which fell to 50.3%, down <a href="https://www.benzinga.com/general/market-summary/25/03/44081294/tariffs-weigh-on-us-manufacturing-february-prices-grow-at-fastest-pace-since-2022">from 50.9% in January.&nbsp;</a>
Overall demand weakened in February, new orders and employment contracted and production growth decelerated sharply. The impact of new tariffs drove prices higher at the fastest pace since June 2022,&nbsp; according to Trading Economics. Additional tariffs are set to go into effect on Tuesday, dampening investor sentiment.&nbsp;
Read Next: <a href="https://www.benzinga.com/general/market-summary/25/02/44015237/pending-home-sales-crash-to-record-low-jobless-claims-soar-wall-street-reacts">Pending Home Sales Crash To Record Low, Jobless Claims Soar: Wall Street Reacts</a>
The tech sector was Monday's worst performer, led lower by Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) and Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>). The SPDR Select Sector Technology Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) was down 0.63% and the tech-heavy Nasdaq 100 slipped 0.5%.&nbsp;
The yield on the 10-year US Treasury note fell to 4.2% on Monday, down 35bps in the last nine sessions. The iShares 20+ Year Treasury Bond ETF was down by 0.16%. 
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and other cryptocurrencies were down after rallying on Sunday following President Trump's announcement of the creation of a strategic reserve that would include bitcoin, Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) and other popular cryptos.&nbsp;
<h2 class="wp-block-heading">Monday's Performance In Major U.S. Indices, ETFs</h2>
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1 day % chg.</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>18,775.16</td>
<td>-0.38%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,943.70</td>
<td>-0.19%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>43,734.63</td>
<td>-0.24%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,148.56</td>
<td>-0.67%</td>
</tr>
</tbody>
</table>
</figure>
According to Benzinga Pro data:
<ul>
<li>The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) slipped 0.15% to $593.29. </li>
<li>The SPDR Dow Jones Industrial Average (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) was down 0.16% at $437.68.&nbsp;</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.03% to $508.33. </li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) eased 0.43% to $213.73.</li>
<li>The Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) rose 0.16% to $216.30. </li>
<li>The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) fell 0.63% to $90.43. </li>
</ul>
<h2 class="wp-block-heading">Monday's Stock Movers: </h2>
Shares of Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) climbed 3% after a Morgan Stanley analyst predicted a rebound in the beaten down stock. Tesla stock remains down <a href="https://www.benzinga.com/government/regulations/25/03/44071203/tesla-falls-nearly-23-destroying-354-billion-of-investor-wealth-in-2025-its-only-going-to-get-worse-says-top-investor">by more</a> than 20% over the past month. 
Stocks reacting to company earnings reports included: 
<ul>
<li>Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>)&nbsp;</li>
<li>Hut 8 Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>)&nbsp;</li>
<li>Fortrea Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>)</li>
<li>Burford Capital Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>)&nbsp;</li>
<li>N-able, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NABL#NYSE">NABL</a>)&nbsp;</li>
<li>Cassava Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>)&nbsp;</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>)</li>
<li>Ready Capital Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RC#NYSE">RC</a>)&nbsp;</li>
<li>Biohaven Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHVN#NYSE">BHVN</a>)&nbsp;</li>
</ul>
Companies reporting after Monday's closing bell include: 
<ul>
<li>B. Riley Financial, Inc.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RILY#NASDAQ">RILY</a>)&nbsp;</li>
<li>Okta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>)&nbsp;</li>
<li>NuScale Power Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>)&nbsp;</li>
<li>GitLab Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>)&nbsp;</li>
<li>Curaleaf Hldgs Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>)&nbsp;</li>
<li>Dave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>)&nbsp;</li>
<li>Emergent BioSolutions Inc.&nbsp; (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>)&nbsp;</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>)&nbsp;</li>
<li>Concentra Group Holdings Parent, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CON#NYSE">CON</a>)&nbsp;</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/econ-s/25/02/43977811/mortgage-rates-drop-to-lowest-levels-since-december-but-housing-market-remains-largely-stuck">Mortgage Rates Drop To Lowest Levels Since December, But Housing Market Remains &#8216;Largely Stuck&#8217;&nbsp;</a></li>
</ul>
Image: Shutterstock

Equities

Large Cap

Market Summary

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Markets

Movers

Tech

ETFs

General

$BTC

$ETH

AMZN

ASTS

AVGO

BHVN

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

DAVE

SPDR Dow Jones Industrial Average ETF Trust

FTRE

GTLB

IBRX

NABL

NOVA

OKTA

RILY

SAVA

TSLA

Select Sector SPDR-Consumer Discretionary

Tesla Rebounds While Tariffs Weigh On Manufacturing: What's Driving Markets Monday?

Burford Capital Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>) shares are trading lower premarket on Monday after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44073292/burford-reports-4q24-and-fy24-financial-results" rel="noreferrer noopener">reported fourth-quarter earnings</a>.
Consolidated total revenues of $93.025 million were down from $292.573 million in the prior year period. Revenues, Total Segments (Burford-only), were $65.692 million, down from $250.615 million in the same period a year earlier.
The company reported&nbsp;an EPS&nbsp;loss of $(0.06), down from an EPS of $0.45 in the year-ago quarter.
Asset Management and Other Services Segment revenue declined to $15.9 million from $24.9 million a year ago quarter,
Net realized gains rose to $141.6 million from $62.9 million in the quarter.
Consolidated cash and marketable securities for Total segments (Burford-only) stood at $521 million as of December 31, 2024 driven by record cash receipts during FY24.
Dividend: On February 28, 2025, Burford&#8217;s Board of Directors announced a final dividend of $0.0625 per ordinary share for the year ended December 31, 2024, payable on June 13, 2025, to shareholders on record as of May 23, 2025.
The company achieved very strong ROICs of 135% in fourth quarter and 179% in second quarter, driving the full-year FY24 ROIC to 108%.
This marks the highest annual result since FY20 and is significantly above the historical average.
Christopher Bogart, Chief Executive Officer, said, "Burford had a splendid 2024. We achieved record-breaking cash realizations with returns well above our historical averages as well as strong growth in new business. We were also added to the Russell indices and cemented our transition to reporting as a US domestic issuer.&#8221;
Price Action: BUR shares are down 6.86% at $14.53 premarket at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/44075328" target="_blank" rel="noreferrer noopener">Eric Trump Says Timing Of Strategic Bitcoin, XRP, Cardano Reserve Announcement Was A &#8216;Win&#8217; For Retail Investors</a></li>
</ul>
Photo via Shutterstock.

Mid Cap

Burford Capital Shares Fall Despite Record Cash Realizations, Q4 Results Disappoint

CORRECTION: Burford Capital Q4 EPS $(0.06) Down From $0.45 YoY, Sales $93.03M Down From $292.54M YoY

Burford Capital shares are trading lower following a Q4 earnings miss.

<h3>Companies Reporting Before The Bell</h3>
• Sphere Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) is expected to report earnings for its second quarter. 
• TG Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGTX#NASDAQ">TGTX</a>) is expected to report quarterly earnings at $0.08 per share on revenue of $99.36 million. 
• Plug Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) is estimated to report quarterly loss at $0.19 per share on revenue of $274.06 million. 
• Burford Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>) is projected to report quarterly earnings at $0.59 per share on revenue of $216.00 million. 
• Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $52.70 million. 
• Mersana Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRSN#NASDAQ">MRSN</a>) is projected to report quarterly loss at $0.16 per share on revenue of $7.64 million. 
• AG Mortgage IT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MITT#NYSE">MITT</a>) is estimated to report quarterly earnings at $0.20 per share on revenue of $17.01 million. 
• Syndax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDX#NASDAQ">SNDX</a>) is likely to report quarterly loss at $1.07 per share on revenue of $21.98 million. 
• Nomad Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOMD#NYSE">NOMD</a>) is estimated to report quarterly earnings at $0.38 per share on revenue of $796.56 million. 
• Ocular Therapeutix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUL#NASDAQ">OCUL</a>) is projected to report quarterly loss at $0.22 per share on revenue of $16.89 million. 
• BioLife Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLFS#NASDAQ">BLFS</a>) is expected to report quarterly loss at $0.03 per share on revenue of $22.77 million. 
• Surgery Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRY#NASDAQ">SGRY</a>) is projected to report quarterly earnings at $0.49 per share on revenue of $828.01 million. 
• N-able (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NABL#NYSE">NABL</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $113.77 million. 
• Ready Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RC#NYSE">RC</a>) is estimated to report quarterly earnings at $0.26 per share on revenue of $55.44 million. 
• Hut 8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) is likely to report quarterly loss at $0.35 per share on revenue of $25.62 million. 
• Stereotaxis (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/STXS#AMEX">STXS</a>) is expected to report quarterly loss at $0.06 per share on revenue of $6.42 million. 
• Sunnova Energy Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) is likely to report quarterly loss at $0.67 per share on revenue of $234.99 million. 
• GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) is likely to report earnings for its fourth quarter. 
• Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) is likely to report quarterly earnings at $0.37 per share on revenue of $703.90 million. 
• California Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRC#NYSE">CRC</a>) is expected to report quarterly earnings at $1.02 per share on revenue of $904.91 million. 
<h3>Companies Reporting After The Bell</h3>
• NuScale Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) is estimated to report quarterly loss at $0.12 per share on revenue of $1.07 million. 
• B. Riley Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RILY#NASDAQ">RILY</a>) is likely to report earnings for its fourth quarter. 
• ADMA Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) is projected to report quarterly earnings at $0.16 per share on revenue of $113.40 million. 
• Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) is expected to report quarterly loss at $0.08 per share on revenue of $5.30 million. 
• GigaCloud Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCT#NASDAQ">GCT</a>) is projected to report quarterly earnings at $0.88 per share on revenue of $288.33 million. 
• Smart Sand (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SND#NASDAQ">SND</a>) is likely to report quarterly earnings at $0.09 per share on revenue of $65.90 million. 
• OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) is estimated to report quarterly earnings at $0.23 per share on revenue of $10.30 million. 
• Fractyl Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GUTS#NASDAQ">GUTS</a>) is likely to report earnings for its fourth quarter. 
• Crawford &amp; Company Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) is estimated to report quarterly earnings at $0.23 per share on revenue of $334.82 million. 
• MRC Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRC#NYSE">MRC</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $726.90 million. 
• W&amp;T Offshore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTI#NYSE">WTI</a>) is expected to report quarterly loss at $0.25 per share on revenue of $130.04 million. 
• Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) is estimated to report quarterly earnings at $1.08 per share on revenue of $95.23 million. 
• AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) is expected to report quarterly loss at $0.15 per share on revenue of $1.88 million. 
• Ranger Energy Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNGR#NYSE">RNGR</a>) is projected to report quarterly earnings at $0.18 per share on revenue of $142.60 million. 
• James River Gr Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) is projected to report quarterly loss at $0.46 per share on revenue of $159.91 million. 
• Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) is likely to report quarterly loss at $0.08 per share on revenue of $270.50 million. 
• Repay Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPAY#NASDAQ">RPAY</a>) is expected to report quarterly earnings at $0.25 per share on revenue of $82.56 million. 
• Viant Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $83.91 million. 
• GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) is expected to report quarterly earnings at $0.23 per share on revenue of $206.48 million. 
• Crawford &amp; Company Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) is projected to report quarterly earnings at $0.24 per share on revenue of $334.82 million. 
• Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) is expected to report quarterly loss at $0.06 per share on revenue of $19.83 million. 
• Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) is likely to report quarterly loss at $0.05 per share on revenue of $53.44 million. 
• Senseonics Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SENS#AMEX">SENS</a>) is projected to report quarterly loss at $0.03 per share on revenue of $7.79 million. 
• Quantum-Si (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) is estimated to report quarterly loss at $0.19 per share on revenue of $1.29 million. 
• NCR Atleos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NATL#NYSE">NATL</a>) is estimated to report quarterly earnings at $1.02 per share on revenue of $1.10 billion. 
• Heidrick &amp; Struggles Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSII#NASDAQ">HSII</a>) is expected to report quarterly earnings at $0.63 per share on revenue of $263.33 million. 
• Concentra Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CON#NYSE">CON</a>) is likely to report quarterly earnings at $0.17 per share on revenue of $463.65 million. 
• ThredUp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDUP#NASDAQ">TDUP</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $70.65 million. 
• Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) is expected to report quarterly earnings at $0.74 per share on revenue of $669.10 million. 
• Kayne Anderson BDC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBDC#NYSE">KBDC</a>) is estimated to report earnings for its fourth quarter. 
• BRC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>) is expected to report quarterly loss at $0.05 per share on revenue of $106.20 million. 
• Whitestone REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSR#NYSE">WSR</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $38.39 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Burford Capital

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL